MDM2 amplification has been detected in many human malignancies, including lung cancer, colon cancer and other malignancies, and the phenomena of amplification occurs more frequently in metastatic and recurrent cancers compared to non-malignant tumors [24]. Here, MDM2 is linked to lung cancer.